DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Org 27569
Org 27569
NIH Public Access Author Manuscript Drug Alcohol Depend
Synthetic Cannabinoids (60 Substances) A) Classical Cannabinoid
Positive Allosteric Modulators (Pams) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain
Cannabinoid Receptor Cannabinoid Receptor
A Cannabinoid CB1 Receptor Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
Appendix-2Final.Pdf 663.7 KB
CB1R Activation in Nucleus Accumbens Core Promotes Stress
Functional Selectivity at the Cannabinoid Receptor Both Endogenously and Exogenously Expressed in a Variety of Cell Lines and Tissues
Synthetic Cannabinoids in Europe
1St Annual Satellite Symposium
Title: Real-Time Characterisation of Cannabinoid Receptor 1 (CB1) Allosteric Modulators Reveals Novel Mechanism of Action
In Vivo Effects of the CB1 Allosteric Modulator LDK1258, a Structural Analog of ORG-27569
The First Application of a Fluorescence-Quenching Assay
Recommended Methods for the Identification and Analysis of Synthetic Cannabinoid Receptor Agonists in Seized Materials
Allosteric Modulators of the CB1 Cannabinoid Receptor
Cannabidiol Is a Negative Allosteric Modulator of the Type 1 Cannabinoid Receptor
International Cannabinoid Research Society
A Potential Target for the Treatment of Various Diseases
Top View
Since the Discovery of the Cannabinoid Receptors and Their
A Guide to Targeting the Endocannabinoid System in Drug Design
Allosteric GPCR Pharmacology
For Review Only
Bioactive Compound Library Plus (96-Well)
Allosteric Modulation of the Cannabinoid CB1 Receptor
Pharmacological Characterization of Repeated Administration of the First Generation Abused Synthetic Cannabinoid CP47,497
Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure
Synthetic Cannabinoids in Europe
Structural Dynamics and Energetics Underlying Allosteric Inactivation of the Cannabinoid Receptor CB1 Jonathan F
NDSP Catalog 23Rd Edition
Neurological Disease
Cannabinoid Receptor Cannabinoid Receptor
Does Modulation of the Endocannabinoid System Have Potential Therapeutic Utility in Cerebellar Ataxia?
Cannabinoid Receptor Ligands
The Study of Allosteric Modulator Sites at the Cannabinoid CB1 Receptor
Synthetic Cannabinoids
GPCR Efficacy and Biased Agonism
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
CB1 Receptor Antagonism Blocks Stress-Potentiated Reinstatement of Cocaine Seeking in Rats
ICRS2012 PROGRAMME and ABSTRACTS